IMMUNIC, INC. — Director's Dealing 2014

Apr 23, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2014-04-23

Reporting Person: Godshall Douglas Evan (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-23	Common Stock	P	12500	$12.00	Acquired	12500	Direct
2014-04-23	Common Stock	C	54018	—	Acquired	66518	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-23	Senior Convertible Preferred Stock	$	C	54018	Disposed		Common Stock (54018)	Direct

Footnotes

F1: Each share of Senior Convertible Preferred Stock automatically converted into the Registrant's common stock on a one-for-one basis immediately prior to the closing of the Registrant's initial public offering and had no expiration date.